OMTX705
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for OMTX705, covering 2025-11-25 to 2026-01-29. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma [Phase 1]